Satisfactory short‐term outcome after anlotinib and docetaxel chemotherapy in tongue cancer with N3 cervical lymph node metastasis: A case report

Patients with tongue squamous cell carcinoma (TSCC) and cervical lymph node metastasis are particularly difficult to treat. This is the first report of about anlotinib combined with docetaxel chemotherapy for chemotherapy‐refractory TSCC with cervical lymph node metastasis, may provide a new, suitab...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yi, Zhong, Zhao‐Yang, Tan, Xiao‐Rong, Wang, Shuai, Qian, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787789/
https://www.ncbi.nlm.nih.gov/pubmed/31624610
http://dx.doi.org/10.1002/ccr3.2390
Descripción
Sumario:Patients with tongue squamous cell carcinoma (TSCC) and cervical lymph node metastasis are particularly difficult to treat. This is the first report of about anlotinib combined with docetaxel chemotherapy for chemotherapy‐refractory TSCC with cervical lymph node metastasis, may provide a new, suitable therapeutic option for these patients.

Ejemplares similares